Nebraska Medicine Hematology/Oncology

www.nebraskamed.com

 

2018 Pan Pacific Lymphoma Conference
J

Novel Cell Pathway Targeted Agents for Relapsed DLBCL

By 2018 Pan Pacific Lymphoma Conference FEATURING Julie M. Vose
By 2018 Pan Pacific Lymphoma Conference FEATURING Julie M. Vose
413 views
August 21, 2018
1 Comment
Login to view comments. Click here to Login

Featured Video

24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi

Featured Video

15:07
Exelixis

Safety and Efficacy Data of a TKI Monotherapy in HCC

Feat. J. Mizrahi
Novel Therapies in Lymphoma
13:17
2018 Pan Pacific Lymphoma Conference

Novel Cell Pathway Targeted Agents for DLBCL: Determining Cell-of-Or…

Feat. J. Vose
25:30
2018 Pan Pacific Lymphoma Conference

How do we Incoporate PET-CT into Standard of Lymphoma Care and Resea…

Feat. B. Cheson
09:28
2018 Pan Pacific Lymphoma Conference

Novel Cell Pathway Targeted Agents for Relapsed DLBCL

Feat. J. Vose
22:02
2018 Pan Pacific Lymphoma Conference

New Antibody-Drug Conjugates

Feat. B. Kahl
17:33
2018 Pan Pacific Lymphoma Conference

Novel-Novel Drug Combinations in B-cell Malignancies

Feat. K. Dunleavy